⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93299 | 1.00 | — | — | |
| SCHEMBL7423636 | 1.00 | — | — | |
| Ethylene SCHEMBL10802720 | 0.93 | — | — | |
| Oxirane SCHEMBL10796207 | 0.90 | — | — | |
| Propylene Oxide SCHEMBL10792620 | 0.87 | — | — | |
| SCHEMBL18652809 | 0.76 | — | — | |
| SCHEMBL8347293 | 0.72 | — | — | |
| SCHEMBL1703680 | 0.72 | — | — | |
| SCHEMBL7527882 | 0.67 | — | — | |
| SCHEMBL7524613 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1673377-B1 | PROCESS FOR THE PREPARATION OF 3-AMINO-2-HYDROXYPROPYLPHOSPHINIC ACID DERIVATIVES | AVENTIS PHARMA INC (US) | 2013-12-25 | — | — | EP | claimed |
| JP-4558732-B2 | — | — | 2010-10-06 | — | — | JP | claimed |
| JP-2007506747-A | — | — | 2007-03-22 | — | — | JP | claimed |
| US-7186705-B2 | Process for the preparation of 3-amino-2-hydroxypropylphosphinic acid derivatives | AVENTIS PHARMACEUTICALS INC. (US) | 2007-03-06 | — | — | US | claimed |
| EP-1673377-A1 | PROCESS FOR THE PREPARATION OF 3-AMINO-2-HYDROXYPROPYLPHOSPHINIC ACID DERIVATIVES | Aventis Pharmaceuticals Inc. (US) | 2006-06-28 | — | — | EP | claimed |
| WO-2005030781-A1 | PROCESS FOR THE PREPARATION OF 3-AMINO-2-HYDROXYPROPYLPHOSPHINIC ACID DERIVATIVES | AVENTIS PHARMACEUTICALS INC. (US) | 2005-04-07 | — | — | WO | claimed |
| US-20050070507-A1 | Process for the preparation of 3-amino-2-hydroxypropylphosphinic acid derivatives | AVENTIS PHARMACEUTICALS INC. (US) | 2005-03-31 | — | — | US | claimed |
| EP-3292114-B1 | 1-HETEROARYL-INDOLINE-4-CARBOXAMIDES AS MODULATORS OF GPR52 USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2020-03-11 | — | — | EP | disclosed |
| CN-108174603-A | 1-heteroaryl-indoline-4-carboxamides as GPR52 modulators for the treatment or prevention of disorders related thereto | 阿芮纳制药有限公司 | 2018-06-15 | — | — | CN | disclosed |
| EP-3292114-A1 | 1-HETEROARYL-INDOLINE-4-CARBOXAMIDES AS MODULATORS OF GPR52 USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2018-03-14 | — | — | EP | disclosed |
| US-9676758-B2 | 1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related thereto | Arena Pharmaceutical, Inc. (US) | 2017-06-13 | — | — | US | disclosed |
| US-20170096441-A1 | PHOSPHONATES WITH REDUCED TOXICITY FOR TREATMENT OF VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-04-06 | — | — | US | disclosed |
| WO-2016176571-A1 | 1-HETEROARYL-INDOLINE-4-CARBOXAMIDES AS MODULATORS OF GPR52 USEFUL FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2016-11-03 | — | — | WO | disclosed |
| EP-2558466-A2 | PHOSPHONATES WITH REDUCED TOXICITY FOR TREATMENT OF VIRAL INFECTIONS | The Regents of the University of California (US) | 2013-02-20 | — | — | EP | disclosed |
| US-20130029940-A1 | PHOSPHONATES WITH REDUCED TOXICITY FOR TREATMENT OF VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-01-31 | — | — | US | disclosed |
| WO-2011130557-A2 | PHOSPHONATES WITH REDUCED TOXICITY FOR TREATMENT OF VIRAL INFECTIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-10-20 | — | — | WO | disclosed |
| US-7186705-B2 | Process for the preparation of 3-amino-2-hydroxypropylphosphinic acid derivatives | AVENTIS PHARMACEUTICALS INC. (US) | 2007-03-06 | — | — | US | disclosed |
| EP-1673377-A1 | PROCESS FOR THE PREPARATION OF 3-AMINO-2-HYDROXYPROPYLPHOSPHINIC ACID DERIVATIVES | Aventis Pharmaceuticals Inc. (US) | 2006-06-28 | — | — | EP | disclosed |
| WO-2005030781-A1 | PROCESS FOR THE PREPARATION OF 3-AMINO-2-HYDROXYPROPYLPHOSPHINIC ACID DERIVATIVES | AVENTIS PHARMACEUTICALS INC. (US) | 2005-04-07 | — | — | WO | disclosed |
| US-20050070507-A1 | Process for the preparation of 3-amino-2-hydroxypropylphosphinic acid derivatives | AVENTIS PHARMACEUTICALS INC. (US) | 2005-03-31 | — | — | US | disclosed |